We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hinge Health and Tripadvisor have been highlighted as Zacks Bull and Bear of the Day
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 10, 2026 – Zacks Equity Research shares Hinge Health, Inc. (HNGE - Free Report) as the Bull of the Day and Tripadvisor, Inc. (TRIP - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Baytex Energy (BTE - Free Report) , Evolution Petroleum (EPM - Free Report) and W&T Offshore (WTI - Free Report) .
Hinge Health, Inc. is a soaring virtual health stock focused on physical therapy, orthopedic care, migraine treatment, gastrointestinal care, and more.
HNGE, which went public in May 2025, is projected to double its revenue between 2025 and 2027, and its upward earnings revisions earn Hinge Health a Zacks Rank #1 (Strong Buy). The digital health firm is gaining steam as it expands its corporate clients (+28% YoY in Q3), which offer their employees access to Hinge’s growing number of AI- and wearable-boosted virtual health offerings.
It is also expanding its margins and free cash flow and diversifying far beyond Hinge’s original focus of musculoskeletal care—think arthritis, back pain, and more—through organic initiatives and acquisitions.
On top of Hinge’s standalone upside in the increasingly important virtual/telehealth industry, HNGE is benefiting from the broader rotation out of artificial intelligence stocks. The medical and healthcare sector is outpacing tech recently, and history shows that healthcare has often outperformed for years after previous boom-and-bust cycles faded.
Best Strong Buy Healthcare Stocks to Buy Amid the AI Selloff
Hinge Health was founded in 2014 on the belief that technology could automate much of physical therapy. The firm boasts that it leverages an “AI-powered care model, wearable devices, and access to expert clinicians” to deliver “personalized, evidence-based care that improves member outcomes and experiences, while reducing costs for clients.”
HNGE offers a digital program that helps people treat joint and muscle pain (like back, knee, or shoulder pain) from home using a smartphone app. It guides users through personalized exercise therapy with AI and motion-tracking technology, and connects them with coaches or physical therapists when needed.
It has also expanded beyond physical therapy into other areas, including digital programs for migraine care and gastrointestinal (GI) issues. Hinge completed its $105 million deal to buy virtual-first digestive healthcare leader Cylinder Health, Inc. in early September.
The purchase is helping it launch an integrated GI segment. Hinge pointed out the massive upside for GI care because GI conditions affect roughly one in four U.S. adults and “drive $135 billion in annual medical spend… and 69% of U.S. counties lack a gastroenterologist.”
All in, Hinge’s pitch to Wall Street, clients, and users is straightforward: it aims to be a go-to company for “virtual and in-person physical therapy, orthopedic care, and more—all accessible through a single app to help provide pain relief from head to toe.”
Buy the Top-Ranked Stock for Its Growth Outlook
Healthcare is getting more expensive, and the U.S. population is growing older. This backdrop is bullish for HNGE since musculoskeletal conditions, issues with bones, joints, muscles, tendons, and ligaments tradiationaly get worse with age. On top of that, digitalizing physical therapy helps cut costs.
HNGE primarily serves self-insured employers and health plans. It grew its clients by 28% YoY to 3,270 at the end of the third quarter. The firm said its client base climbed roughly 30% for its MSK Care Program, ~40% for its GI Care Program since its Cylinder Health acquisition, and roughly doubled for its Migraine Care Program.
It expanded its total quarterly revenue by 52% YoY and soared from a GAAP loss of $6.1 million in the year-ago period to +$50.3 million. Hinge also more than doubled its adjusted EPS to $0.71 a share. In the first nine months of 2026, Hinge more than doubled its free cash (+115% YoY) to $253.8 million.
HNGE raised its fiscal 2026 guidance after the strong report on November 2. Its upward EPS revisions earn it a Zacks Rank #1 (Strong Buy) and extend a strong run of positivity. Its adjusted earnings are projected to slip slightly (-4%) in 2026 as it invests in expansion, with the firm expected to boost its EPS by 27% next year to $3.18 a share vs. $2.51 expected this year. The chart above highlights Hinge’s long-term earnings growth outlook.
The digital healthcare firm is projected to expand its revenue by 50% in 2026 and another 28% next year to roughly double its sales from $587.9 million in 2025 to $1.13 billion in FY27.
Buy #1 (Strong Buy) Telehealth Stock HNGE Now?
HNGE shares have jumped ~14% in the past month vs. the S&P 500’s 6% drop and Tech’s 15% fall. This is part of a 160% YTD climb and a ~220% run since its May 2025 IPO. Hinge is trading right near its recent peaks, and its average Zacks price target implies 14% upside.
The stock has been hugging its 21-day moving average since breaking out meaningfully above its summer levels in early October. Hinge found support at its 21-day moving average late last week, and the stock could be ready to climb higher, especially if the rotation out of Tech and AI continues.
All-in investors should consider buying the Zacks Rank #1 (Strong Buy) digital musculoskeletal care stock since Hinge operates across unique, yet growth-focused segments of the wider healthcare world.
Tripadvisor, Inc. is an online travel platform titan that helps users find hotels, experiences, restaurants, and more through its core Tripadvisor brand and beyond.
TRIP’s earnings outlook has tumbled over the past year as AI disruptions continue to dent Tripadvisor’s traffic. Tripadvisor missed our adjusted Q3 earnings estimates by 29% when it reported on November 5, and it provided another round of disappointing guidance.
Tripadvisor’s downbeat earnings revisions picture lands it a Zacks Rank #5 (Strong Sell) right now.
Should Investors Avoid TRIP Stock Right Now?
Tripadvisor is part of the vanguard of the internet travel planning and booking industry. TRIP generates revenue primarily from advertising, bookings, and experiences. The firm posted strong revenue growth in its early years as a public company and its quickly rebounded after the Covid-induced decline to post three straight years of booming sales expansion between 2021 and 2023.
The rapid expansion of artificial intelligence has disrupted its original travel planning and booking business. Tripadvisor is attempting to shift its focus toward its higher-growth Experiences (via Viator) unit while managing a declining Hotels & Other segment that historically relied heavily on search-driven traffic.
Despite its overall success, TRIP struggled to turn profits even before AI shook up its core business. Now the situation is far worse. Its Q3 revenue dropped 11%, and it posted a large GAAP net loss of roughly $317 million (or about -$2.70 per share), reflecting a non-cash goodwill impairment charge of $369.5 million tied to the Hotels & Other segment.
Management attributed the impairment largely to sustained declines in performance and reduced future profitability expectations, “largely due to the multi-period acceleration of traffic headwinds resulting from changes in the search landscape.”
Meanwhile, its adjusted EPS came in at $0.37, missing the Zacks consensus estimate by 29%. Its Hotels & Other revenue fell 23%, and Experiences revenue declined 3%.
The company also announced that CEO Matt Goldberg will step down in mid-February 2027 and CFO Mike Noonan will depart at the end of 2026, adding to the uncertainty as it pursues a restructuring expected to deliver roughly $40 million in annualized savings.
Tripadvisor cut its earnings outlook, with its adjusted Q4 estimate down from $0.21 before its release to $0.14. TRIP’s adjusted fiscal 2026 earnings are projected to drop 30% on 17% lower sales. Worse still, its most accurate fourth-quarter estimate calls for TRIP to report an adjusted loss of -$0.14 a share. Plus, its most accurate estimate for FY26 came in 47% below its already reduced outlook.
Tripadvisor’s recent downward EPS revisions earn it a Zacks Rank #5 (Strong Sell). On top of that, it is part of the Internet-Commerce industry that is facing broad pressure from evolving search and AI dynamics.
Additional content:
3 Value Stocks Under $5 to Buy Amid Oil Price Volatility
Oil prices have come under pressure as hopes of easing tensions between the United States and Iran reduce concerns about global supplies. After climbing above $100 a barrel in late October, U.S. crude has fallen toward $90, while Brent has slipped below $100. The sharp decline followed the U.S. midterm elections and signs that Washington may avoid further military action against Iran. Despite the recent sell-off, uncertainty surrounding Middle East oil shipments may create buying opportunities for investors seeking exposure to commodity-related stocks.
Three energy stocks investors may consider buying are Baytex Energy, Evolution Petroleum and W&T Offshore. These companies offer exposure to oil and natural gas production, with Baytex operating in Canada and the United States, Evolution Petroleum holding interests in producing U.S. oil and gas properties, and W&T Offshore focusing on offshore production in the Gulf of Mexico.
Their different business models offer investors exposure to oil and natural gas markets amid changing market conditions. Moreover, all three stocks carry a Value Score of A or B, making them potential buying opportunities for value-oriented investors despite the prevailing market uncertainty.
Can Oil Prices Recover from the Recent Sell-Off?
Oil prices have fallen sharply as expectations of a possible resolution to the U.S.-Iran conflict have eased fears of major supply disruptions. The recent U.S. midterm election results raised hopes that Washington would seek to end the conflict sooner. President Donald Trump also indicated that further strikes on Iran are unlikely if negotiations make progress. These developments helped push Brent below $100 a barrel and U.S. crude toward $90, following one of the steepest weekly declines in years.
Looking ahead, oil prices remain sensitive to developments in the Middle East. Recent attacks on vessels near the Strait of Hormuz and renewed tensions involving Saudi Arabia continue to raise concerns about shipping and supply disruptions. While progress in diplomatic talks may pressure crude prices, fresh attacks could trigger another recovery. With U.S. crude trading around $90, continued supply risks may support prices, creating potential buying opportunities in select energy stocks.
Why Buy These Value-Priced Energy Stocks Under $5?
Against this backdrop, investors seeking affordable energy stocks may consider companies trading below $5 — often referred to as penny stocks — that offer attractive valuations and the potential to benefit from a recovery in oil prices. Oil and gas producers may gain from stronger crude prices and improved operating performance, making select low-priced stocks worth considering. Although these stocks carry higher risks and may experience sharp price swings, companies with reasonable valuations and sound fundamentals may present buying opportunities for investors willing to accept the uncertainty.
3 Stocks to Buy
W&T Offshore: W&T Offshore is a Houston-based oil and natural gas producer focused on offshore fields in the Gulf of America. Founded in 1983, the company operates properties in both shallow and deep waters. Its business has grown largely through buying producing fields, then using its technical experience and existing infrastructure to manage them efficiently.
Instead of relying heavily on new drilling, W&T often improves production by repairing wells, reopening productive zones and upgrading facilities. This approach helps control spending and extend the useful life of its assets. The Zacks Rank #1 (Strong Buy) company continues to look for attractive acquisitions while prioritizing cash flow, debt reduction and shareholder returns. You can see the complete list of today’s Zacks #1 Rank stocks here.
WTI shares trade for around $3.09 as of this writing. An incredible bargain for investors, the Zacks Consensus Estimate for 2026 earnings of the company indicates 86.5% growth. W&T Offshore has a Value Score of B.
Baytex Energy: Baytex Energy is a Canadian oil and natural gas producer with operations concentrated in Alberta and Saskatchewan. Its portfolio combines heavy oil production with lighter oil resources in the Duvernay and Viking areas. Heavy oil forms the foundation of the business, while Duvernay development is becoming an increasingly important source of growth.
Baytex is expanding drilling activity as improved efficiency helps lower costs and bring new wells into production faster. It is also testing methods to recover more oil from existing fields, including water injection and thermal development. The company plans to balance production growth with disciplined spending, share buybacks and dividends.
At just over $4 per share and with a Value Score of A, Zacks Rank #2 (Buy) BTE presents an appealing option for energy sector investors looking for a stock with a reasonable valuation. The Zacks Consensus Estimate for 2026 earnings of the company indicates 213.5% growth.
Evolution Petroleum: Evolution Petroleum is an independent U.S. energy company with interests in oil and natural gas properties across several states. Rather than operating wells itself, the company partners with established producers and earns a share of production revenue. Its assets span Texas, Louisiana, Oklahoma, New Mexico, Wyoming and North Dakota, giving it exposure to different energy markets.
Evolution is also expanding its mineral and royalty holdings, which generate income from wells developed by other operators without requiring it to fund drilling. Recent purchases have strengthened its presence in the Permian Basin and Louisiana. The #2 Ranked company, with a Value Score of B, aims to support steady cash flow, selective growth and regular shareholder dividends.
With a share price of just $3.48, EPM is a stock that energy sector investors should add to their portfolio. Over the past 60 days, the Zacks Consensus Estimate for the company’s fiscal 2027 earnings has gone up 66.7%.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index.Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
Hinge Health and Tripadvisor have been highlighted as Zacks Bull and Bear of the Day
For Immediate Release
Chicago, IL – November 10, 2026 – Zacks Equity Research shares Hinge Health, Inc. (HNGE - Free Report) as the Bull of the Day and Tripadvisor, Inc. (TRIP - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Baytex Energy (BTE - Free Report) , Evolution Petroleum (EPM - Free Report) and W&T Offshore (WTI - Free Report) .
Here is a synopsis of all five stocks.
Bull of the Day:
Hinge Health, Inc. is a soaring virtual health stock focused on physical therapy, orthopedic care, migraine treatment, gastrointestinal care, and more.
HNGE, which went public in May 2025, is projected to double its revenue between 2025 and 2027, and its upward earnings revisions earn Hinge Health a Zacks Rank #1 (Strong Buy). The digital health firm is gaining steam as it expands its corporate clients (+28% YoY in Q3), which offer their employees access to Hinge’s growing number of AI- and wearable-boosted virtual health offerings.
It is also expanding its margins and free cash flow and diversifying far beyond Hinge’s original focus of musculoskeletal care—think arthritis, back pain, and more—through organic initiatives and acquisitions.
On top of Hinge’s standalone upside in the increasingly important virtual/telehealth industry, HNGE is benefiting from the broader rotation out of artificial intelligence stocks. The medical and healthcare sector is outpacing tech recently, and history shows that healthcare has often outperformed for years after previous boom-and-bust cycles faded.
Best Strong Buy Healthcare Stocks to Buy Amid the AI Selloff
Hinge Health was founded in 2014 on the belief that technology could automate much of physical therapy. The firm boasts that it leverages an “AI-powered care model, wearable devices, and access to expert clinicians” to deliver “personalized, evidence-based care that improves member outcomes and experiences, while reducing costs for clients.”
HNGE offers a digital program that helps people treat joint and muscle pain (like back, knee, or shoulder pain) from home using a smartphone app. It guides users through personalized exercise therapy with AI and motion-tracking technology, and connects them with coaches or physical therapists when needed.
It has also expanded beyond physical therapy into other areas, including digital programs for migraine care and gastrointestinal (GI) issues. Hinge completed its $105 million deal to buy virtual-first digestive healthcare leader Cylinder Health, Inc. in early September.
The purchase is helping it launch an integrated GI segment. Hinge pointed out the massive upside for GI care because GI conditions affect roughly one in four U.S. adults and “drive $135 billion in annual medical spend… and 69% of U.S. counties lack a gastroenterologist.”
All in, Hinge’s pitch to Wall Street, clients, and users is straightforward: it aims to be a go-to company for “virtual and in-person physical therapy, orthopedic care, and more—all accessible through a single app to help provide pain relief from head to toe.”
Buy the Top-Ranked Stock for Its Growth Outlook
Healthcare is getting more expensive, and the U.S. population is growing older. This backdrop is bullish for HNGE since musculoskeletal conditions, issues with bones, joints, muscles, tendons, and ligaments tradiationaly get worse with age. On top of that, digitalizing physical therapy helps cut costs.
HNGE primarily serves self-insured employers and health plans. It grew its clients by 28% YoY to 3,270 at the end of the third quarter. The firm said its client base climbed roughly 30% for its MSK Care Program, ~40% for its GI Care Program since its Cylinder Health acquisition, and roughly doubled for its Migraine Care Program.
It expanded its total quarterly revenue by 52% YoY and soared from a GAAP loss of $6.1 million in the year-ago period to +$50.3 million. Hinge also more than doubled its adjusted EPS to $0.71 a share. In the first nine months of 2026, Hinge more than doubled its free cash (+115% YoY) to $253.8 million.
HNGE raised its fiscal 2026 guidance after the strong report on November 2. Its upward EPS revisions earn it a Zacks Rank #1 (Strong Buy) and extend a strong run of positivity. Its adjusted earnings are projected to slip slightly (-4%) in 2026 as it invests in expansion, with the firm expected to boost its EPS by 27% next year to $3.18 a share vs. $2.51 expected this year. The chart above highlights Hinge’s long-term earnings growth outlook.
The digital healthcare firm is projected to expand its revenue by 50% in 2026 and another 28% next year to roughly double its sales from $587.9 million in 2025 to $1.13 billion in FY27.
Buy #1 (Strong Buy) Telehealth Stock HNGE Now?
HNGE shares have jumped ~14% in the past month vs. the S&P 500’s 6% drop and Tech’s 15% fall. This is part of a 160% YTD climb and a ~220% run since its May 2025 IPO. Hinge is trading right near its recent peaks, and its average Zacks price target implies 14% upside.
The stock has been hugging its 21-day moving average since breaking out meaningfully above its summer levels in early October. Hinge found support at its 21-day moving average late last week, and the stock could be ready to climb higher, especially if the rotation out of Tech and AI continues.
All-in investors should consider buying the Zacks Rank #1 (Strong Buy) digital musculoskeletal care stock since Hinge operates across unique, yet growth-focused segments of the wider healthcare world.
Bear of the Day:
Tripadvisor, Inc. is an online travel platform titan that helps users find hotels, experiences, restaurants, and more through its core Tripadvisor brand and beyond.
TRIP’s earnings outlook has tumbled over the past year as AI disruptions continue to dent Tripadvisor’s traffic. Tripadvisor missed our adjusted Q3 earnings estimates by 29% when it reported on November 5, and it provided another round of disappointing guidance.
Tripadvisor’s downbeat earnings revisions picture lands it a Zacks Rank #5 (Strong Sell) right now.
Should Investors Avoid TRIP Stock Right Now?
Tripadvisor is part of the vanguard of the internet travel planning and booking industry. TRIP generates revenue primarily from advertising, bookings, and experiences. The firm posted strong revenue growth in its early years as a public company and its quickly rebounded after the Covid-induced decline to post three straight years of booming sales expansion between 2021 and 2023.
The rapid expansion of artificial intelligence has disrupted its original travel planning and booking business. Tripadvisor is attempting to shift its focus toward its higher-growth Experiences (via Viator) unit while managing a declining Hotels & Other segment that historically relied heavily on search-driven traffic.
Despite its overall success, TRIP struggled to turn profits even before AI shook up its core business. Now the situation is far worse. Its Q3 revenue dropped 11%, and it posted a large GAAP net loss of roughly $317 million (or about -$2.70 per share), reflecting a non-cash goodwill impairment charge of $369.5 million tied to the Hotels & Other segment.
Management attributed the impairment largely to sustained declines in performance and reduced future profitability expectations, “largely due to the multi-period acceleration of traffic headwinds resulting from changes in the search landscape.”
Meanwhile, its adjusted EPS came in at $0.37, missing the Zacks consensus estimate by 29%. Its Hotels & Other revenue fell 23%, and Experiences revenue declined 3%.
The company also announced that CEO Matt Goldberg will step down in mid-February 2027 and CFO Mike Noonan will depart at the end of 2026, adding to the uncertainty as it pursues a restructuring expected to deliver roughly $40 million in annualized savings.
Tripadvisor cut its earnings outlook, with its adjusted Q4 estimate down from $0.21 before its release to $0.14. TRIP’s adjusted fiscal 2026 earnings are projected to drop 30% on 17% lower sales. Worse still, its most accurate fourth-quarter estimate calls for TRIP to report an adjusted loss of -$0.14 a share. Plus, its most accurate estimate for FY26 came in 47% below its already reduced outlook.
Tripadvisor’s recent downward EPS revisions earn it a Zacks Rank #5 (Strong Sell). On top of that, it is part of the Internet-Commerce industry that is facing broad pressure from evolving search and AI dynamics.
Additional content:
3 Value Stocks Under $5 to Buy Amid Oil Price Volatility
Oil prices have come under pressure as hopes of easing tensions between the United States and Iran reduce concerns about global supplies. After climbing above $100 a barrel in late October, U.S. crude has fallen toward $90, while Brent has slipped below $100. The sharp decline followed the U.S. midterm elections and signs that Washington may avoid further military action against Iran. Despite the recent sell-off, uncertainty surrounding Middle East oil shipments may create buying opportunities for investors seeking exposure to commodity-related stocks.
Three energy stocks investors may consider buying are Baytex Energy, Evolution Petroleum and W&T Offshore. These companies offer exposure to oil and natural gas production, with Baytex operating in Canada and the United States, Evolution Petroleum holding interests in producing U.S. oil and gas properties, and W&T Offshore focusing on offshore production in the Gulf of Mexico.
Their different business models offer investors exposure to oil and natural gas markets amid changing market conditions. Moreover, all three stocks carry a Value Score of A or B, making them potential buying opportunities for value-oriented investors despite the prevailing market uncertainty.
Can Oil Prices Recover from the Recent Sell-Off?
Oil prices have fallen sharply as expectations of a possible resolution to the U.S.-Iran conflict have eased fears of major supply disruptions. The recent U.S. midterm election results raised hopes that Washington would seek to end the conflict sooner. President Donald Trump also indicated that further strikes on Iran are unlikely if negotiations make progress. These developments helped push Brent below $100 a barrel and U.S. crude toward $90, following one of the steepest weekly declines in years.
Looking ahead, oil prices remain sensitive to developments in the Middle East. Recent attacks on vessels near the Strait of Hormuz and renewed tensions involving Saudi Arabia continue to raise concerns about shipping and supply disruptions. While progress in diplomatic talks may pressure crude prices, fresh attacks could trigger another recovery. With U.S. crude trading around $90, continued supply risks may support prices, creating potential buying opportunities in select energy stocks.
Why Buy These Value-Priced Energy Stocks Under $5?
Against this backdrop, investors seeking affordable energy stocks may consider companies trading below $5 — often referred to as penny stocks — that offer attractive valuations and the potential to benefit from a recovery in oil prices. Oil and gas producers may gain from stronger crude prices and improved operating performance, making select low-priced stocks worth considering. Although these stocks carry higher risks and may experience sharp price swings, companies with reasonable valuations and sound fundamentals may present buying opportunities for investors willing to accept the uncertainty.
3 Stocks to Buy
W&T Offshore: W&T Offshore is a Houston-based oil and natural gas producer focused on offshore fields in the Gulf of America. Founded in 1983, the company operates properties in both shallow and deep waters. Its business has grown largely through buying producing fields, then using its technical experience and existing infrastructure to manage them efficiently.
Instead of relying heavily on new drilling, W&T often improves production by repairing wells, reopening productive zones and upgrading facilities. This approach helps control spending and extend the useful life of its assets. The Zacks Rank #1 (Strong Buy) company continues to look for attractive acquisitions while prioritizing cash flow, debt reduction and shareholder returns. You can see the complete list of today’s Zacks #1 Rank stocks here.
WTI shares trade for around $3.09 as of this writing. An incredible bargain for investors, the Zacks Consensus Estimate for 2026 earnings of the company indicates 86.5% growth. W&T Offshore has a Value Score of B.
Baytex Energy: Baytex Energy is a Canadian oil and natural gas producer with operations concentrated in Alberta and Saskatchewan. Its portfolio combines heavy oil production with lighter oil resources in the Duvernay and Viking areas. Heavy oil forms the foundation of the business, while Duvernay development is becoming an increasingly important source of growth.
Baytex is expanding drilling activity as improved efficiency helps lower costs and bring new wells into production faster. It is also testing methods to recover more oil from existing fields, including water injection and thermal development. The company plans to balance production growth with disciplined spending, share buybacks and dividends.
At just over $4 per share and with a Value Score of A, Zacks Rank #2 (Buy) BTE presents an appealing option for energy sector investors looking for a stock with a reasonable valuation. The Zacks Consensus Estimate for 2026 earnings of the company indicates 213.5% growth.
Evolution Petroleum: Evolution Petroleum is an independent U.S. energy company with interests in oil and natural gas properties across several states. Rather than operating wells itself, the company partners with established producers and earns a share of production revenue. Its assets span Texas, Louisiana, Oklahoma, New Mexico, Wyoming and North Dakota, giving it exposure to different energy markets.
Evolution is also expanding its mineral and royalty holdings, which generate income from wells developed by other operators without requiring it to fund drilling. Recent purchases have strengthened its presence in the Permian Basin and Louisiana. The #2 Ranked company, with a Value Score of B, aims to support steady cash flow, selective growth and regular shareholder dividends.
With a share price of just $3.48, EPM is a stock that energy sector investors should add to their portfolio. Over the past 60 days, the Zacks Consensus Estimate for the company’s fiscal 2027 earnings has gone up 66.7%.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
https://www.zacks.com
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index.Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.